Zobrazeno 1 - 10
of 245
pro vyhledávání: '"Alex H Kral"'
Autor:
Bethany Hedden-Clayton, Jes Cochran, Jennifer J. Carroll, Alex H. Kral, Grant Victor, Erin Comartin, Bradley Ray
Publikováno v:
Drug and Alcohol Dependence Reports, Vol 12, Iss , Pp 100250- (2024)
Introduction: An unpredictable illicit drug supply is driving high levels of overdose death in North America. Prior research has demonstrated the importance of involving people who use drugs in harm reduction intervention design and implementation. T
Externí odkaz:
https://doaj.org/article/65be574d926a4c1ca9e58074889b811d
Autor:
Barrot H. Lambdin, Ricky N. Bluthenthal, Bryan R. Garner, Lynn D. Wenger, Erica N. Browne, Terry Morris, Lee Ongais, Cariné E. Megerian, Alex H. Kral
Publikováno v:
Implementation Science, Vol 19, Iss 1, Pp 1-12 (2024)
Abstract Background The United States (US) continues to face decades-long increases in opioid overdose fatalities. As an opioid overdose reversal medication, naloxone can dramatically reduce opioid overdose mortality rates when distributed to people
Externí odkaz:
https://doaj.org/article/fd41c3370944450cb1da4603f33d110a
Autor:
Eric O Johnson, Dana B Hancock, Nathan C Gaddis, Joshua L Levy, Grier Page, Scott P Novak, Cristie Glasheen, Nancy L Saccone, John P Rice, Michael P Moreau, Kimberly F Doheny, Jane M Romm, Andrew I Brooks, Bradley E Aouizerat, Laura J Bierut, Alex H Kral
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0118149 (2015)
Fifty percent of variability in HIV-1 susceptibility is attributable to host genetics. Thus identifying genetic associations is essential to understanding pathogenesis of HIV-1 and important for targeting drug development. To date, however, CCR5 rema
Externí odkaz:
https://doaj.org/article/fd28aa1c0fea4988aacabbe825e692bb
Autor:
Eric O Johnson, Dana B Hancock, Nathan C Gaddis, Joshua L Levy, Grier Page, Scott P Novak, Cristie Glasheen, Nancy L Saccone, John P Rice, Michael P Moreau, Kimberly F Doheny, Jane M Romm, Andrew I Brooks, Alex H Kral
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0129671 (2015)
Externí odkaz:
https://doaj.org/article/febf30308ac74183af2838b4450f13c2
Autor:
Bradley R. Ray, Jamie L. Humphrey, Sheila V. Patel, Christopher F. Akiba, Ricky N. Bluthenthal, Hansel Tookes, Paul A. LaKosky, Lynn D. Wenger, Alex H. Kral, Barrot H. Lambdin
Publikováno v:
The Lancet Regional Health. Americas, Vol 34, Iss , Pp 100757- (2024)
Summary: Background: Syringe services programmes (SSPs) are an evidence-based strategy to reduce infectious diseases and deliver overdose prevention interventions for people who use drugs. They face regulatory, administrative, and funding barriers th
Externí odkaz:
https://doaj.org/article/8f22b2839ae14462b4b3a64647868a18
Autor:
Christopher F. Akiba, Jessica Smith, Lynn D. Wenger, Terry Morris, Sheila V. Patel, Ricky N. Bluthenthal, Hansel E. Tookes, Paul LaKosky, Alex H. Kral, Barrot H. Lambdin
Publikováno v:
SSM: Qualitative Research in Health, Vol 5, Iss , Pp 100421- (2024)
Syringe Services Programs (SSPs) provide evidence-based services like drug use equipment to prevent infectious disease, overdose prevention education, and naloxone distribution to people who use drugs (PWUD). However, inadequate funding threatens pro
Externí odkaz:
https://doaj.org/article/7509fc120b5b41828cb95c04902d241f
Autor:
Tyler S. Bartholomew, Hansel E. Tookes, Teresa A. Chueng, Ricky N. Bluthenthal, Lynn D. Wenger, Alex H. Kral, Barrot H. Lambdin
Publikováno v:
Harm Reduction Journal, Vol 20, Iss 1, Pp 1-7 (2023)
Abstract Introduction The expanded capacity of syringe services programs (SSPs) in the USA to integrate telehealth services was largely related to flexibility of buprenorphine prescription in response to the COVID-19 pandemic. SSPs demonstrated the p
Externí odkaz:
https://doaj.org/article/d7a7752a7ce3477ab0ee4b899f11233e
Autor:
Christopher F. Akiba, Sheila V. Patel, Lynn D. Wenger, Antonio Morgan-Lopez, Gary A. Zarkin, Stephen Orme, Peter J. Davidson, Alex H. Kral, Barrot H. Lambdin
Publikováno v:
Implementation Science, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Background More than half a million Americans died of an opioid-related overdose between 1999 and 2020, the majority occurring between 2015 and 2020. The opioid overdose mortality epidemic disproportionately impacts Black, Indigenous, and pe
Externí odkaz:
https://doaj.org/article/ce807b78667c4b00970cb23827f64560
Autor:
Sheila V. Patel, Lynn D. Wenger, Alex H. Kral, Kenneth Sherr, Anjuli D. Wagner, Peter J. Davidson, Barrot H. Lambdin
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Opioid overdose fatalities are preventable with timely administration of naloxone, an opioid antagonist, during an opioid overdose event. Syringe service programs have pioneered naloxone distribution for potential bystanders of op
Externí odkaz:
https://doaj.org/article/2102a5472f27401bb6660043ef963c70
Autor:
Barrot H. Lambdin, Lynn Wenger, Ricky Bluthenthal, Tyler S. Bartholomew, Hansel E. Tookes, Paul LaKosky, Savannah O’Neill, Alex H. Kral
Publikováno v:
Harm Reduction Journal, Vol 20, Iss 1, Pp 1-7 (2023)
Abstract Background Naloxone is a medication that can quickly reverse an opioid overdose. Syringe service programs (SSPs) are community-based prevention programs that provide a range of evidence-based interventions in the USA, including naloxone dist
Externí odkaz:
https://doaj.org/article/7de863ab027a4d508cc8bd8f3973d053